DPP9 inhibition boosts antitumor immunity by disrupting BRISC-mediated PD-L1 expression in clear cell renal cell carcinoma

Xue G, Li X, Kalim M, Fang J, Jiang Z, Zheng N, et al. Clinical ...

Nimbolide ameliorates ARDS and ulcerative colitis by disrupting NLRP3 inflammasome activation

Coll, R. C. & Schroder, K. Inflammasome components as new therapeutic targets in inflammatory disease. ...